2298-36-4

Basic information

• Product Name: 2-(4-AMINOPHENOXY)ACETIC ACID HYDRATE
• Synonyms: 2-(4-AMINOPHENOXY)ACETIC ACID;2-(4-AMINOPHENOXY)ACETIC ACID HYDRATE;AKOS BC-1107;(4-AMINO-PHENOXY)-ACETIC ACID;TIMTEC-BB SBB001635;(p-aminophenoxy)acetic acid;2-(4-azanylphenoxy)ethanoic acid;Acetic acid, 2-(4-aMinophenoxy)-
• CAS NO: 2298-36-4
• Molecular Formula: C₈H₉NO₃
• Molecular Weight: 167.16
• EINECS: 218-947-5
• Product Categories: Phenoxyacetic Acids and Alcohols (substituted)
• Mol File: 2298-36-4.mol

Chemical Properties

• Melting Point: 132 °C
• Boiling Point: 366.868 °C at 760 mmHg
• Flash Point: 175.676 °C
• Appearance: /
• Density: 1.317g/cm³
• Vapor Pressure: 4.99E-06mmHg at 25°C
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 2.98±0.10(Predicted)
• CAS DataBase Reference: 2-(4-AMINOPHENOXY)ACETIC ACID HYDRATE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-AMINOPHENOXY)ACETIC ACID HYDRATE(2298-36-4)
• EPA Substance Registry System: 2-(4-AMINOPHENOXY)ACETIC ACID HYDRATE(2298-36-4)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• HazardClass: IRRITANT
• Hazardous Substances Data: 2298-36-4(Hazardous Substances Data)

Usage

Uses

Used in Chemical Industry:
2-(4-AMINOPHENOXY)ACETIC ACID HYDRATE is used as a chemical intermediate for the synthesis of various compounds in the chemical industry. Its unique structure with an aminophenol group and an acetic acid moiety allows it to be a versatile building block for the creation of new molecules.
Used in Biochemical Research:
2-(4-AMINOPHENOXY)ACETIC ACID HYDRATE is used as a research tool in biochemical studies. Its presence in biochemical research may involve the investigation of its interactions with biological systems, potential applications in drug development, or as a component in the synthesis of bioactive molecules.

InChI:InChI=1/C8H9NO3.H2O/c9-6-1-3-7(4-2-6)12-5-8(10)11;/h1-4H,5,9H2,(H,10,11);1H2

Upstream product

• 1798-11-4 4-nitrophenoxyacetic acid 
• 123-30-8 4-amino-phenol 
• 79-08-3 bromoacetic acid 
• 103790-30-3 [4-(toluene-4-sulfonylamino)-phenoxy]-acetic acid ethyl ester 
• 103-90-2 4-acetaminophenol 
• 824-78-2 4-nitrophenol sodium salt 
• 901451-30-7 (4-Amino-phenoxy)-acetic acid methoxycarbonylmethyl ester 
• 3926-62-3 sodium monochloroacetic acid 
• 67202-81-7 ethyl 2-[4-(acetylamino)phenoxy]acetate 
• 79-11-8 chloroacetic acid 
• 901451-18-1 (4-Amino-phenoxy)-acetic acid 2-hydroxy-ethyl ester 
• 39149-13-8 p-N-acetylaminophenoxyacetic acid 

Downstream Products

• 59954-04-0 methyl 4-aminophenoxyacetate 
• 1878-94-0 4-iodophenoxyacetic acid 
• 20485-38-5 ethyl 2-(4-aminophenoxy)acetate 
• 69447-81-0 (4-hydrazino-phenoxy)-acetic acid 
• 39149-13-8 p-N-acetylaminophenoxyacetic acid 
• 293761-49-6 (4-benzoylamino-phenoxy)-acetic acid 
• 861366-31-6 N-(4-carboxymethoxy-phenyl)-glycine 
• 117885-82-2 [4-(2-chloro-acetylamino)-phenoxy]-acetic acid 
• 77645-41-1 [4-(toluene-4-sulfonylamino)-phenoxy]-acetic acid 
• 103790-30-3 [4-(toluene-4-sulfonylamino)-phenoxy]-acetic acid ethyl ester 
• 58183-76-9 [4-(3-p-Tolyl-propionylamino)-phenoxy]-acetic acid 

Relevant articles and documents

Use of novel haptens in the production of antibodies for the detection of tryptamines

Tryptamines are a group of hallucinogenic drugs whose detection in body fluids could be simplified by immunochemical assay kits. Antibodies for these assays are obtained by the immunization of laboratory animals with conjugates of a hapten similar to the target analyte and a suitable protein. Therefore we synthesized novel haptens derived from tryptamine-based drugs, with N,N-dimethyltryptamine (DMT), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and N,N-diisopropyltryptamine (DiPT) selected as the target analytes. Their structures were modified with a short linker ended with a carboxylic group. The haptens were conjugated with bovine serum albumin (BSA) and rabbits were immunized with the conjugates. The obtained polyclonal antibodies showed good reactivity and the LOD of the constructed ELISAs was in the range 0.006-0.254 ng mL-1. Thus, they are suitable for the development of immunochemical assay kits.

Design, synthesis and in vivo screening of some novel quinazoline analogs as anti-hyperlipidemic and hypoglycemic agents

A novel series of substituted quinazoline derivatives were designed, synthesized and evaluated for their hypolipidemic activity in cholesterol induced hyperlipidemic rats. In vivo screening concluded that compounds A-4, C-5 and C-6 have shown potent antihyperlipidemic activity by decreasing the plasma level of triglycerides (TG), very low density lipoprotein (VLDL), low density lipoprotein (LDL), followed by increase in level of high density lipoprotein (HDL).

Convergent Versus Divergent Three-Step Synthesis of the First (4-Aminophenoxy)alkanoic Acid-Based Tripodal Melamines

Starting from N-(4-hydroxyphenyl)acetamide (Paracetamol, convergent approach) or from cyanuric chloride in reaction with 4-aminophenol (divergent approach), two synthetic routes toward novel tripodal N-substituted melamines as s-triazine derivatives of (4-aminophenoxy)acetic acid or of 4-(4-aminophenoxy)butyric acid are comparatively defined. The key steps consist of Williamson etherification of N-masked forms of 4-aminophenol and acidic hydrolysis of the N- and/or O-protected (4-aminophenoxy)alkanoic segments.

FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM

The present invention relates to compounds of formula I, which are functionalized phenolic compounds, and polymers formed from the same. Ar—[O—(X)p—R′]q??I Polymers formed from the functionalized phenolics are expected to have controllable degradation profiles, enabling them to release an active component over a desired time range. The polymers are also expected to be useful in a variety of medical applications.

Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin

Plasmepsin (Plm) is a potential target for new antimalarial drugs, but most reported Plm inhibitors have relatively low antimalarial activities. We synthesized a series of dipeptide-type HIV protease inhibitors, which contain an allophenylnorstatine-dimethylthioproline scaffold to exhibit potent inhibitory activities against Plm II. Their activities against Plasmodium falciparum in the infected erythrocyte assay were largely different from those against the target enzyme. To improve the antimalarial activity of peptidomimetic Plm inhibitors, we attached substituents on a structure of the highly potent Plm inhibitor KNI-10006. Among the derivatives, we identified alkylamino compounds such as 44 (KNI-10283) and 47 (KNI-10538) with more than 15-fold enhanced antimalarial activity, to the sub-micromolar level, maintaining their potent Plm II inhibitory activity and low cytotoxicity. These results suggest that auxiliary substituents on a specific basic group contribute to deliver the inhibitors to the target Plm.

Functionalized drugs and polymers derived therefrom

Compounds selected from: where DRUG-OH, DRUG-COOH and DRUG-NH2 are biologically active compounds; each X is independently selected from —CH2COO— (glycolic acid moiety), —CH(CH3)COO— (lactic acid moiety), —CH2CH2OCH2COO— (dioxanone moiety), —CH2CH2CH2CH2CH2COO— (caprolactone moiety), —(CH2)yCOO—, where y is 2-4 or 6-24 and —(CH2CH2O)zCH2COO—, where z is 2-24; each Y is independently selected from —COCH2O— (glycolic ester moiety), —COCH(CH3)O— (lactic ester moiety), —COCH2OCH2CH2O— (dioxanone ester moiety), —COCH2CH2CH2CH2CH2O— (caprolactone ester moiety), —CO(CH2)mO—, where m is 2-4 or 6-24 and —COCH2O(CH2CH2O)n— where n is between 2-24; R′ is hydrogen, benzyl or an alkyl group, the alkyl group being either straight-chained or branched; and p is 1-6. Multi-functional compounds and drug dimers, oligomers and polymers are also disclosed.

One step hair coloring compositions using salts

A hair coloring composition comprising the following two compositions which are mixed just prior to application to the hair: (a) a composition comprising a water-soluble peroxygen oxidizing agent; and (b) a composition comprising one or more oxidative hair coloring agents selected from the group consisting of an aromatic diamine, an amino phenol, a naphthol, a polyhydric phenol, a catechol and mixtures thereof; wherein the composition comprising one or more oxidative hair coloring agents further comprises al least one water soluble carbonate releasing salts; and optionally a water soluble ammonium salt, is described.

Disazo dyes and inks containing them

A compound of Formula (1) and salts thereof are useful as dyes for ink jet printing inks. In the formula (1), A is optionally substituted phenyl (other than carboxyl substituted); R1and R2are each independently optionally substituted alkyl or optionally substituted alkoxy; and R4and R5are each independently H, alkyl or optionally substituted aryl. In formula (1) at least one of R1and R2carries an —OH group.

Hair colouring and conditioning compositions

A hair colouring and conditioning composition comprising: (a) a hair colouring agent; and (b) a hair conditioning agent; wherein the composition provides an Average Combing Index Value of greater than 1.2 as measured by the Combing Technical Test Method. The products can provide excellent hair colouring together with excellent conditioning, reduced hair damage, brittleness and dryness, and is convenient and easy to use.

Enhanced color deposition for hair with sequestering agents

Hair coloring compositions which comprise: (A) non-nitrogenous chelating agents from the group consisting of polyphosphate; phosphonates; hydroxycarboxylates; polyacrylates; zeolite; and mixtures thereof; (B) an oxidative dye primary intermediate; and (C) an oxidative dye coupler; (D) and water are described. The present invention also relates to a method for coloring hair which comprises contacting said hair with a hair coloring composition as described above.